Maker

Value

Hedge

<div class="textg" style="text-align: justify; font-weight: lighter; line-height: 1.3em; font-size: 15px; border-radius: 3px; color: #80909a; padding: 10px; background-color: #F4F6F9; margin-bottom: 15px;">
 Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult our&nbsp;<a href="https://tokenist.com/terms-of-service/" style="text-decoration:underline;color:#3c7b7b" target="_blank" rel="noopener noreferrer nofollow" class="deco-link">website policy</a>&nbsp;prior to making financial decisions.
</div>
<p class="has-drop-cap">Hedge fund Starboard Value has reportedly taken a stake in Kenvue Inc. (NYSE: KVUE), the consumer products spinoff from Johnson &amp; Johnson (NYSE: JNJ). The news, <a aria-label="reported (opens in a new tab)" href="https://www.reuters.com/markets/deals/activist-investor-starboard-value-takes-stake-consumer-products-maker-kenvue-2024-10-21/" target="_blank" rel="noopener noreferrer nofollow" class="deco-link">reported</a> on October 20, 2024, by Reuters, comes as Kenvue’s stock has struggled since its public debut in May 2023, falling 18% and valuing the company at $41 billion.</p>
<h3 id="activist-investor-starboard-value-takes-stake-in-jnj-consumer-products-spinoff-company">Activist Investor Starboard Value Takes Stake in JNJ Consumer Products Spinoff Company</h3>
<p>Starboard Value, known for its activist positions in companies, may push Kenvue to review its brand positioning and pricing strategies. The hedge fund’s chief investment officer, Jeffrey Smith, is scheduled to present investment ideas at the upcoming 13D Monitor Active-Passive Investor Summit. This move follows Starboard’s recent $1 billion investment in pharmaceutical giant Pfizer.<br><br>Kenvue, maker of household names such as Band-Aid, Listerine, and Tylenol, was <a href="https://investors.kenvue.com/financial-news/news-details/2023/Kenvue-Becomes-a-Fully-Independent-Company-Following-Final-Separation-from-Johnson--Johnson/default.aspx" target="_blank" aria-label="spun off (opens in a new tab)" rel="noopener noreferrer nofollow" class="deco-link">spun off</a> from Johnson &amp; Johnson in May 2023. The company operates in the consumer products sector, focusing on personal care and over-the-counter medications.</p>
<div class="cta-referral"><img src="https://tokenist.com/wp-content/themes/thetokenist/assets/img/del/cta-referral-1.png" alt="" class="cta-referral__img" loading="lazy" decoding="async">
 <div class="cta-referral__text">
  <p>Join our&nbsp;<a href="https://t.me/thetokenist" target="_blank" rel="noopener noreferrer nofollow" class="deco-link">Telegram group&nbsp;and never miss a breaking story.</a></p>
 </div>
</div>
<h3 id="kenvue-stocks-jump-on-activist-investor-news">Kenvue Stocks Jump on Activist Investor News</h3>
<p>Following the news, Kenvue’s stock showed significant movement in pre-market trading. After closing at $21.72 on Friday, the stock jumped to $23.40 in <a href="https://tokenist.com/investing/how-to-trade-after-hours/" rel="noopener noreferrer nofollow" class="deco-link">pre-market activity</a>, representing a 7.73% increase. <br><br>This surge brings Kenvue’s share price closer to analyst price targets, which range from $21.00 to $27.00.<br>For retail investors, Starboard’s involvement could signal potential changes in Kenvue’s business strategy aimed at improving performance and stock price. <br><br>However, it’s important to note that activist investors often push for significant operational changes, which could lead to short-term stock volatility. The long-term implications will depend on the specific actions Starboard proposes and their implementation.</p>
<p>Kenvue’s financial metrics reveal a mixed picture. With a market capitalization of $41.597 billion, the company trades at a <a href="https://tokenist.com/investing/p-e-ratio/" rel="noopener noreferrer nofollow" class="deco-link">price-to-earnings ratio</a> of 38.11, with a forward P/E of 17.57. <br><br>Kenvue’s year-to-date return of 4.00% lags behind <a href="https://tokenist.com/investing/spx-vs-spy/" rel="noopener noreferrer nofollow" class="deco-link">the S&amp;P 500’s 22.95% gain</a>, although its one-year return of 14.39% shows some promise.</p> <iframe src="https://tokenist.substack.com/embed" width="100%" height="320" style="border:1px solid #EEE; background:white;" frameborder="0" scrolling="no"></iframe>
<p><em>Disclaimer: The author does not hold or have a position in any securities discussed in the article.</em></p>
<h3 id="br"><br></h3>
<p>The post <a rel="noopener noreferrer nofollow" href="https://tokenist.com/activist-investor-starboard-acquires-stake-in-band-aid-maker-kenvue-shares-jump/">Activist Investor Starboard Acquires Stake in Band-Aid Maker Kenvue, Shares Jump</a> appeared first on <a rel="noopener noreferrer nofollow" href="https://tokenist.com">Tokenist</a>.</p>

Activist Investor Starboard Acquires Stake in Band-Aid Maker Kenvue, Shares Jump

Table of Contents

Tokenist

Other articles published on Oct 21, 2024

Derivio Launches “Play-to-Earn” Telegram DApp, Integrating Social Engagement and Gameplay

JustMarkets Launches Enhanced Practice Account to Elevate Forex Trading Skills

Experts See BlockDAG Hitting $600M Target in Just 2 Months! TRON Rises & Polkadot Shows Bullish S...

Reku Berharap Segera Kantongi Lisensi sebagai PFAK

Investor Earns $620,000 from a $296 Memecoin Investment

Vitalik Buterin’s Pioneering Plan to Cut Centralization in Ethereum POS

Join our free newsletter for daily crypto updates!